Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, BMCH, BLDR, CIT, EV, EIDX, NAV, STND and WTRE
NEW YORK, Nov. 25, 2020 /PRNewswire/ --
American Renal Associates Holdings, Inc. (NYSE: ARA)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of ARA to affiliates of Nautic Partners for $11.50 per share.
If you are ARA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
BMC Stock Holdings, Inc. (NASDAQ: BMCH) -Builders FirstSource, Inc. (NASDAQ: BLDR)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BMCH to BLDR.
If you are a BMCH or BLDR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
CIT Group Inc. (NYSE: CIT)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CIT to First Citizens BancShares, Inc. for 0.0620 shares of First Citizens class A common stock per share.
If you are a CIT investor, and would like additional information about our investigation, please complete the Information Request Form.
Eaton Vance Corp. (NYSE: EV)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of EV to Morgan Stanley.
If you are a EV or MS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Eidos Therapeutics, Inc. (NASDAQ: EIDX) - BridgeBio Pharma, Inc. (NASDAQ: BBIO)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of EIDX to BBIO for approximately $73.26 per share.
If you are a EIDX or BBIO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Navistar International Corporation (NASDAQ: NAV)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of NAV to Traton SE for $44.50 per share.
If you are a NAV investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Standard AVB Financial Corp. (NASDAQ GS: STND)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of STND to Dollar Mutual Bancorp.
If you are a STND investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Watford Holdings Ltd. (NASDAQ: WTRE)
Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of WTRE to Arch Capital Group Ltd. for $31.10 per share.
If you are a WTRE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
View original content:http://www.prnewswire.com/news-releases/lifshitz-law-firm-pc-announces-investigation-of-ara-bbio-bmch-bldr-cit-ev-eidx-nav-stnd-and-wtre-301180367.html
SOURCE Lifshitz & Miller Law Firm

Related Stories
-
Analyst Actions: Mizuho Securities Adjusts Price Target on BridgeBio Pharma to $56 From $51, Maintains Buy Rating
MT Newswires 12/02 06:51 ET -
Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – MVC, PTI, CGIX, STND
Globe Newswire 12/01 19:14 ET -
Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – ARA, PNM, IPHI, EIGI
Globe Newswire 12/01 19:09 ET -
Distribution Dates and Amounts Announced for Eaton Vance Closed-End Funds
PR Newswire 12/01 19:02 ET -
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of ELY, MVC, GV, and STND Mergers
Globe Newswire 12/01 11:46 ET -
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of IPHI, ARA, PNM, and EIGI Buyouts
Globe Newswire 12/01 11:27 ET -
BridgeBio Pharma, QED Therapeutics Receive FDA Acceptance of New Drug Application for Liver Cancer Drug Candidate
MT Newswires 12/01 09:42 ET -
CIT Arranges $75 Million Credit Facility for One Call Corporation
PR Newswire 12/01 09:00 ET -
BridgeBio Pharma and Affiliate QED Therapeutics Announce FDA Acceptance of New Drug Application for Infigratinib for the Treatment of Cholangiocarcinoma
Globe Newswire 12/01 07:30 ET -
Is EAFAX a Strong Bond Fund Right Now?
Yahoo 12/01 07:00 ET